Table 3.
RV longitudinal strain in HF patients with preserved traditional RV function parameters.
| Reference | Sample Size | Age (Years), Mean ± SD |
Study Design | LVEF (%) | RVGLS (%) | RVFWLS (%) | Software | Device |
|---|---|---|---|---|---|---|---|---|
| Morris et al. [89] | 218 a 208 b |
72.0 ± 10.5 a 67.4 ± 14.1 b |
Prospective | 61.9 ± 6.1 a 35.4 ± 9.6 b |
2D-STE-RVGLS: −20.7 ± 4.0 a −15.3 ± 4.7 b |
2D-STE-RVFWLS: −24.6 ± 5.1 a −19.0 ± 5.8 b |
Echo-Pac 113, GE | Vivid 7 or E9 (GE Healthcare) |
| Carluccio et al. [24] | 200 | 66 ± 11 | Prospective | 30 ± 7 | 2D-STE-RVFWLS: −20.9 ± 5.9 c −16.7 ± 5.6 d |
EchoPac 112.1.5; General Electric-Vingmed | (Vivid 7, Vivid S6; General Electric Vingmed, Horton, Norway |
a Patients with HFpEF; b Patients with HFrEF; c Patients without event (cardiovascular death, hospitalization for acute HF, heart transplantation, intra-aortic balloon pump implantation, and ventricular assist device implantation); d Patients with event (cardiovascular death, hospitalization for acute HF, heart transplantation, intra-aortic balloon pump implantation, and ventricular assist device implantation).